UNC Metastatic Cancer Radiation Therapy Registry

UNC Lineberger Comprehensive Cancer Center

Status: Enrolling

Conditions: Metastatic Cancer; Cancer

Treatments: Radiation: Radiation therapy

Study type: Observational

Funder types: Other

Identifiers

NCT06306924

LCCC2303

Details and patient eligibility

About

The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Written informed consent was obtained to participate in the study and HIPAA

Authorization for release of personal health information. Ability to understand and willingness to sign informed consent

Diagnosed with or is suspected to have metastatic cancer.

Age ≥ 18 years at the time of consent.

Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.

Exclusion criteria

All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study:

Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.

Trial design

2,000 participants in 1 patient group

Palliative radiation therapy

Description:

Subjects who are with metastatic cancer receive palliative radiation therapy.

Treatment:

Radiation: Radiation therapy